Orior AG (ORON)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 12.70 |
|---|---|
| 52-week range | 9.50 – 17.70 |
| Return, 1 month / 3 months | −0.8% / −17.1% |
| Return, 1 year / 3 years | −2.8% / −79.9% |
| Trend | Below its 200-day average |
| RSI (14) | 50 |
| Volatility (1 year) | 42.9% |
| Worst drawdown (1 year) | -30.3% |
| Average daily value traded | 0.19M CHF |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Orior is a Swiss food company based in Zurich that makes meat products, convenience foods and vegetarian alternatives. Its brands cover sausages, charcuterie, ready meals, sauces and plant-based foods, produced at sites in Switzerland and nearby European countries. The company supplies supermarkets, food retailers and food-service customers, and its products reach consumers mainly in Switzerland and the surrounding region.
On this site Orior AG appears as a stock on the SIX Swiss Exchange (Switzerland), code ORON, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Orior AG (ORON) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 12.70 on 22 October 2026.
Its price-based Market X-Ray is 31 out of 100 (a weak price profile), ranking 184 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 2.8% and over the last three months it fell 17.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 39 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.9% | ||
| From 52-week high | -24.0% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.1% | ||
| 6-month return | -3.3% | ||
| 12-month return, skipping the last month | -2.0% | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.3% | ||
| Liquidity | 30 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.19M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | −0.8% |
| 3 months | −17.1% |
| 6 months | −3.3% |
| 1 year | −2.8% |
| 3 years | −79.9% |
| 5 years | −84.0% |
Signals
| 50-day / 200-day average | 13.08 / 12.94 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.46 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2025 | CHF 1.5000 |
| 27 May 2024 | CHF 2.5100 |
| 21 Apr 2023 | CHF 0.6500 |
| 7 Apr 2022 | CHF 1.2000 |
| 28 Apr 2021 | CHF 1.1600 |
| 8 Jun 2020 | CHF 1.1600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.